In an interview with ACT senior editor Andy Studna at the 2025 DIA Global Annual Meeting, Carie Pierce, SVP, global head of growth & business development, DIA, discusses the growing emphasis on ...

Global R&D leaders discuss the need for collaboration in medical research and how regulatory agencies are working to create the proper environment for advancements.

Balancing the emerging benefits of AI in pharmacovigilance with new responsibilities and demands from regulators in enhancing ...

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

In this Q&A, Megan Bailey, EVP and president of central laboratories and international, Labcorp, discusses how central labs ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer ...

Clinical trials face a critical challenge: bridging the gap between patient curiosity and motivation to participate, ...

Clinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data ...

Cross-sector partnership launches EQBMED. Initially funded by PhRMA and established as a cross-sector collaborative, ...

Clinical trial processes lag behind scientific and technological advances. While the science and tools exist to run faster, more inclusive, and efficient trials, outdated mindsets, rigid protocols, ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer ...